カテゴリ： 世界, 医療/バイオ, QYResearch

前頭側頭型認知症治療薬の世界市場2023年：抗うつ剤、抗精神病薬

■ 英語タイトル：Global Frontotemporal Dementia Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8765）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8765
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[前頭側頭型認知症治療薬の世界市場2023年：抗うつ剤、抗精神病薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は前頭側頭型認知症治療薬のグローバル市場について調査・分析し、世界の前頭側頭型認知症治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（抗うつ剤、抗精神病薬）、用途別セグメント分析（病院薬局、小売店薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Sanofi S.A.、Novartis AG、F. Hoffmann-La Roche、AstraZeneca GmbH、Merck & Co.、Valeant Pharmaceutical International、Pfizerなどが含まれています。前頭側頭型認知症治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、前頭側頭型認知症治療薬市場規模を算出する際に考慮しました。

・前頭側頭型認知症治療薬市場の概要
- 前頭側頭型認知症治療薬の種類別セグメント
- 世界の前頭側頭型認知症治療薬市場規模：タイプ別分析（抗うつ剤、抗精神病薬）
- 前頭側頭型認知症治療薬の用途別セグメント
- 世界の前頭側頭型認知症治療薬市場規模：用途別分析（病院薬局、小売店薬局、その他）
- 世界の前頭側頭型認知症治療薬市場規模予測（2018年-2029年）

・前頭側頭型認知症治療薬市場の成長トレンド
- 前頭側頭型認知症治療薬の地域別市場規模（2018年-2029年）
- 前頭側頭型認知症治療薬市場ダイナミクス
- 前頭側頭型認知症治療薬の業界動向
- 前頭側頭型認知症治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：抗うつ剤、抗精神病薬
- 世界の前頭側頭型認知症治療薬のタイプ別市場規模（2018年-2023年）
- 世界の前頭側頭型認知症治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院薬局、小売店薬局、その他
- 世界の前頭側頭型認知症治療薬の用途別市場規模（2018年-2023年）
- 世界の前頭側頭型認知症治療薬の用途別市場規模（2024年-2029年）

・前頭側頭型認知症治療薬の地域別市場規模
- 北米の前頭側頭型認知症治療薬市場規模（2018年-2029年）
- 米国の前頭側頭型認知症治療薬市場規模（2018年-2029年）
- ヨーロッパの前頭側頭型認知症治療薬市場規模（2018年-2029年）
- アジア太平洋の前頭側頭型認知症治療薬市場規模（2018年-2029年）
- 中国の前頭側頭型認知症治療薬市場規模（2018年-2029年）
- 日本の前頭側頭型認知症治療薬市場規模（2018年-2029年）
- 韓国の前頭側頭型認知症治療薬市場規模（2018年-2029年）
- インドの前頭側頭型認知症治療薬市場規模（2018年-2029年）
- オーストラリアの前頭側頭型認知症治療薬市場規模（2018年-2029年）
- 中南米の前頭側頭型認知症治療薬市場規模（2018年-2029年）
- 中東・アフリカの前頭側頭型認知症治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Sanofi S.A.、Novartis AG、F. Hoffmann-La Roche、AstraZeneca GmbH、Merck & Co.、Valeant Pharmaceutical International、Pfizer

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Frontotemporal Dementia Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Frontotemporal Dementia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Frontotemporal Dementia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Frontotemporal Dementia Treatment in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Frontotemporal Dementia Treatment include Sanofi S.A., Novartis AG, F. Hoffmann-La Roche, AstraZeneca GmbH, Merck & Co., Valeant Pharmaceutical International and Pfizer, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Frontotemporal Dementia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Frontotemporal Dementia Treatment.
The Frontotemporal Dementia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Frontotemporal Dementia Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Frontotemporal Dementia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sanofi S.A.
Novartis AG
F. Hoffmann-La Roche
AstraZeneca GmbH
Merck & Co.
Valeant Pharmaceutical International
Pfizer
Segment by Type
Antidepressants
Antipsychotics
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Frontotemporal Dementia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Frontotemporal Dementia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antidepressants
1.2.3 Antipsychotics
1.3 Market by Application
1.3.1 Global Frontotemporal Dementia Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Frontotemporal Dementia Treatment Market Perspective (2018-2029)
2.2 Frontotemporal Dementia Treatment Growth Trends by Region
2.2.1 Global Frontotemporal Dementia Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Frontotemporal Dementia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Frontotemporal Dementia Treatment Forecasted Market Size by Region (2024-2029)
2.3 Frontotemporal Dementia Treatment Market Dynamics
2.3.1 Frontotemporal Dementia Treatment Industry Trends
2.3.2 Frontotemporal Dementia Treatment Market Drivers
2.3.3 Frontotemporal Dementia Treatment Market Challenges
2.3.4 Frontotemporal Dementia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Frontotemporal Dementia Treatment Players by Revenue
3.1.1 Global Top Frontotemporal Dementia Treatment Players by Revenue (2018-2023)
3.1.2 Global Frontotemporal Dementia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Frontotemporal Dementia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Frontotemporal Dementia Treatment Revenue
3.4 Global Frontotemporal Dementia Treatment Market Concentration Ratio
3.4.1 Global Frontotemporal Dementia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Frontotemporal Dementia Treatment Revenue in 2022
3.5 Frontotemporal Dementia Treatment Key Players Head office and Area Served
3.6 Key Players Frontotemporal Dementia Treatment Product Solution and Service
3.7 Date of Enter into Frontotemporal Dementia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Frontotemporal Dementia Treatment Breakdown Data by Type
4.1 Global Frontotemporal Dementia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Frontotemporal Dementia Treatment Forecasted Market Size by Type (2024-2029)
5 Frontotemporal Dementia Treatment Breakdown Data by Application
5.1 Global Frontotemporal Dementia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Frontotemporal Dementia Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Frontotemporal Dementia Treatment Market Size (2018-2029)
6.2 North America Frontotemporal Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Frontotemporal Dementia Treatment Market Size by Country (2018-2023)
6.4 North America Frontotemporal Dementia Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Frontotemporal Dementia Treatment Market Size (2018-2029)
7.2 Europe Frontotemporal Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Frontotemporal Dementia Treatment Market Size by Country (2018-2023)
7.4 Europe Frontotemporal Dementia Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Frontotemporal Dementia Treatment Market Size (2018-2029)
8.2 Asia-Pacific Frontotemporal Dementia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Frontotemporal Dementia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Frontotemporal Dementia Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Frontotemporal Dementia Treatment Market Size (2018-2029)
9.2 Latin America Frontotemporal Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Frontotemporal Dementia Treatment Market Size by Country (2018-2023)
9.4 Latin America Frontotemporal Dementia Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Frontotemporal Dementia Treatment Market Size (2018-2029)
10.2 Middle East & Africa Frontotemporal Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Frontotemporal Dementia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Frontotemporal Dementia Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Detail
11.1.2 Sanofi S.A. Business Overview
11.1.3 Sanofi S.A. Frontotemporal Dementia Treatment Introduction
11.1.4 Sanofi S.A. Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.1.5 Sanofi S.A. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Frontotemporal Dementia Treatment Introduction
11.2.4 Novartis AG Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.2.5 Novartis AG Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Frontotemporal Dementia Treatment Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 AstraZeneca GmbH
11.4.1 AstraZeneca GmbH Company Detail
11.4.2 AstraZeneca GmbH Business Overview
11.4.3 AstraZeneca GmbH Frontotemporal Dementia Treatment Introduction
11.4.4 AstraZeneca GmbH Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.4.5 AstraZeneca GmbH Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Frontotemporal Dementia Treatment Introduction
11.5.4 Merck & Co. Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.5.5 Merck & Co. Recent Development
11.6 Valeant Pharmaceutical International
11.6.1 Valeant Pharmaceutical International Company Detail
11.6.2 Valeant Pharmaceutical International Business Overview
11.6.3 Valeant Pharmaceutical International Frontotemporal Dementia Treatment Introduction
11.6.4 Valeant Pharmaceutical International Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.6.5 Valeant Pharmaceutical International Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Frontotemporal Dementia Treatment Introduction
11.7.4 Pfizer Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.7.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Frontotemporal Dementia Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antidepressants
Table 3. Key Players of Antipsychotics
Table 4. Global Frontotemporal Dementia Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Frontotemporal Dementia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Frontotemporal Dementia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Frontotemporal Dementia Treatment Market Share by Region (2018-2023)
Table 8. Global Frontotemporal Dementia Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Frontotemporal Dementia Treatment Market Share by Region (2024-2029)
Table 10. Frontotemporal Dementia Treatment Market Trends
Table 11. Frontotemporal Dementia Treatment Market Drivers
Table 12. Frontotemporal Dementia Treatment Market Challenges
Table 13. Frontotemporal Dementia Treatment Market Restraints
Table 14. Global Frontotemporal Dementia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Frontotemporal Dementia Treatment Market Share by Players (2018-2023)
Table 16. Global Top Frontotemporal Dementia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frontotemporal Dementia Treatment as of 2022)
Table 17. Ranking of Global Top Frontotemporal Dementia Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Frontotemporal Dementia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Frontotemporal Dementia Treatment Product Solution and Service
Table 21. Date of Enter into Frontotemporal Dementia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Frontotemporal Dementia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Frontotemporal Dementia Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Frontotemporal Dementia Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Frontotemporal Dementia Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Frontotemporal Dementia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Frontotemporal Dementia Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Frontotemporal Dementia Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Frontotemporal Dementia Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Frontotemporal Dementia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Frontotemporal Dementia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Frontotemporal Dementia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Frontotemporal Dementia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Frontotemporal Dementia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Frontotemporal Dementia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Frontotemporal Dementia Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Frontotemporal Dementia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Frontotemporal Dementia Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Frontotemporal Dementia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Frontotemporal Dementia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Frontotemporal Dementia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Frontotemporal Dementia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Frontotemporal Dementia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Frontotemporal Dementia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Sanofi S.A. Company Detail
Table 47. Sanofi S.A. Business Overview
Table 48. Sanofi S.A. Frontotemporal Dementia Treatment Product
Table 49. Sanofi S.A. Revenue in Frontotemporal Dementia Treatment Business (2018-2023) & (US$ Million)
Table 50. Sanofi S.A. Recent Development
Table 51. Novartis AG Company Detail
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Frontotemporal Dementia Treatment Product
Table 54. Novartis AG Revenue in Frontotemporal Dementia Treatment Business (2018-2023) & (US$ Million)
Table 55. Novartis AG Recent Development
Table 56. F. Hoffmann-La Roche Company Detail
Table 57. F. Hoffmann-La Roche Business Overview
Table 58. F. Hoffmann-La Roche Frontotemporal Dementia Treatment Product
Table 59. F. Hoffmann-La Roche Revenue in Frontotemporal Dementia Treatment Business (2018-2023) & (US$ Million)
Table 60. F. Hoffmann-La Roche Recent Development
Table 61. AstraZeneca GmbH Company Detail
Table 62. AstraZeneca GmbH Business Overview
Table 63. AstraZeneca GmbH Frontotemporal Dementia Treatment Product
Table 64. AstraZeneca GmbH Revenue in Frontotemporal Dementia Treatment Business (2018-2023) & (US$ Million)
Table 65. AstraZeneca GmbH Recent Development
Table 66. Merck & Co. Company Detail
Table 67. Merck & Co. Business Overview
Table 68. Merck & Co. Frontotemporal Dementia Treatment Product
Table 69. Merck & Co. Revenue in Frontotemporal Dementia Treatment Business (2018-2023) & (US$ Million)
Table 70. Merck & Co. Recent Development
Table 71. Valeant Pharmaceutical International Company Detail
Table 72. Valeant Pharmaceutical International Business Overview
Table 73. Valeant Pharmaceutical International Frontotemporal Dementia Treatment Product
Table 74. Valeant Pharmaceutical International Revenue in Frontotemporal Dementia Treatment Business (2018-2023) & (US$ Million)
Table 75. Valeant Pharmaceutical International Recent Development
Table 76. Pfizer Company Detail
Table 77. Pfizer Business Overview
Table 78. Pfizer Frontotemporal Dementia Treatment Product
Table 79. Pfizer Revenue in Frontotemporal Dementia Treatment Business (2018-2023) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Frontotemporal Dementia Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Frontotemporal Dementia Treatment Market Share by Type: 2022 VS 2029
Figure 3. Antidepressants Features
Figure 4. Antipsychotics Features
Figure 5. Global Frontotemporal Dementia Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Frontotemporal Dementia Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Frontotemporal Dementia Treatment Report Years Considered
Figure 11. Global Frontotemporal Dementia Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Frontotemporal Dementia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Frontotemporal Dementia Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Frontotemporal Dementia Treatment Market Share by Players in 2022
Figure 15. Global Top Frontotemporal Dementia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frontotemporal Dementia Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Frontotemporal Dementia Treatment Revenue in 2022
Figure 17. North America Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Frontotemporal Dementia Treatment Market Share by Country (2018-2029)
Figure 19. United States Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Frontotemporal Dementia Treatment Market Share by Country (2018-2029)
Figure 23. Germany Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Frontotemporal Dementia Treatment Market Share by Region (2018-2029)
Figure 31. China Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Frontotemporal Dementia Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Frontotemporal Dementia Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Frontotemporal Dementia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Sanofi S.A. Revenue Growth Rate in Frontotemporal Dementia Treatment Business (2018-2023)
Figure 46. Novartis AG Revenue Growth Rate in Frontotemporal Dementia Treatment Business (2018-2023)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Frontotemporal Dementia Treatment Business (2018-2023)
Figure 48. AstraZeneca GmbH Revenue Growth Rate in Frontotemporal Dementia Treatment Business (2018-2023)
Figure 49. Merck & Co. Revenue Growth Rate in Frontotemporal Dementia Treatment Business (2018-2023)
Figure 50. Valeant Pharmaceutical International Revenue Growth Rate in Frontotemporal Dementia Treatment Business (2018-2023)
Figure 51. Pfizer Revenue Growth Rate in Frontotemporal Dementia Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 双極性障害治療のグローバル市場展望 2023年-2029年：気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬
  • 慢性疲労症候群治療薬のグローバル市場展望 2023年-2029年：鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬
  • 認知症用GPSトラッカーのグローバル市場展望 2023年-2029年：ウェアラブル型、持ち運び型
  • 結膜炎治療の世界市場インサイト・予測（～2028年）
  • 好酸球性喘息治療薬の世界市場2023年：静脈内注射、皮下注射
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8765 )"前頭側頭型認知症治療薬の世界市場2023年：抗うつ剤、抗精神病薬" (英文：Global Frontotemporal Dementia Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。